<DOC>
	<DOCNO>NCT00297830</DOCNO>
	<brief_summary>The purpose study compare effectiveness safety zoledronic acid alendronate prevention bone loss organ transplantation . Zoledronic acid give single intravenous infusion . Alendronate give weekly pill . Both expected effective , know one work best .</brief_summary>
	<brief_title>Zoledronic Acid Versus Alendronate Prevention Bone Loss After Organ Transplantation</brief_title>
	<detailed_description>Patients undergone heart liver transplantation usually require remain medication , Prednisone Cyclosporine A Tacrolimus , prevent body reject transplanted organ . These medication may cause bone loss lead thin bone ( osteoporosis ) therefore greatly increase risk broken bone ( fracture ) transplantation . Several publish study show 14 % 35 % heart transplant patient develop fracture ( spine , rib hip ) first year transplantation . We previously show alendronate ( Fosamax ) , drug approve FDA prevention treatment postmenopausal osteoporosis prednisone-induced osteoporosis , prevent bone loss heart transplantation . We conduct study determine whether new drug , zoledronic acid , effective alendronate . This study randomize , double-blind , placebo-controlled 2-year study . Participants receive one dose active zoledronic acid first month heart liver transplantation weekly placebo alendronate pill one dose placebo zoledronic acid weekly active alendronate pill first year transplant . Over 2 year , participant provide blood sample nine occasion . Bone density perform 4-5 time spine xrays perform twice .</detailed_description>
	<mesh_term>Bone Resorption</mesh_term>
	<mesh_term>Zoledronic acid</mesh_term>
	<mesh_term>Alendronate</mesh_term>
	<mesh_term>Diphosphonates</mesh_term>
	<criteria>A man woman , age 20 70 , race heart liver transplant hyperparathyroidism Paget 's disease hyperthyroidism cancer severe kidney disease , intestinal disease active peptic ulcer disease current past treatment osteoporosis pregnancy lactation severe oral/dental disease</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Heart Transplantation</keyword>
	<keyword>Liver Transplantation</keyword>
	<keyword>Immunosuppression</keyword>
	<keyword>Bone Density/drug effect</keyword>
	<keyword>Alendronate</keyword>
	<keyword>Zoledronic acid</keyword>
	<keyword>Comparative study</keyword>
	<keyword>Humans</keyword>
</DOC>